002773 康弘藥業
按盤價 
30.760 -0.410 (-1.315%)
30.760 -0.410 (-1.315%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 11.593 | 14.477 | 14.209 | 13.804 | 7.110 |
| 總資產報酬率 ROA (%) | 10.753 | 13.331 | 12.858 | 12.219 | 6.034 |
| 投入資產回報率 ROIC (%) | 11.553 | 14.402 | 14.057 | 13.516 | 6.877 | 邊際利潤分析 |
| 銷售毛利率 (%) | 90.329 | 89.524 | 88.922 | 88.550 | 90.164 |
| 營業利潤率 (%) | 33.889 | 31.023 | 31.866 | 29.960 | 9.851 |
| 息稅前利潤/營業總收入 (%) | 32.201 | 28.976 | 29.857 | 29.075 | 9.960 |
| 淨利潤/營業總收入 (%) | 28.178 | 26.434 | 26.055 | 25.547 | 11.679 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 98.086 | 95.563 | 93.231 | 88.628 | 111.772 |
| 價值變動淨收益/利潤總額(%) | 0.856 | 3.417 | 3.582 | 3.694 | 6.717 |
| 營業外收支淨額/利潤總額(%) | -1.625 | -2.129 | -2.200 | 1.449 | 9.721 | 償債能力分析 |
| 流動比率 (X) | 10.356 | 9.601 | 8.107 | 6.097 | 5.542 |
| 速動比率 (X) | 9.786 | 9.011 | 7.490 | 5.620 | 5.099 |
| 資產負債率 (%) | 7.295 | 7.440 | 8.415 | 10.541 | 12.235 |
| 帶息債務/全部投入資本 (%) | -0.153 | -0.067 | -0.149 | -0.179 | -0.232 |
| 股東權益/帶息債務 (%) | -65,097.901 | -148,405.851 | -66,839.353 | -55,068.346 | -41,848.930 |
| 股東權益/負債合計 (%) | 1,273.141 | 1,244.941 | 1,087.270 | 848.043 | 715.530 |
| 利息保障倍數 (X) | -28.101 | -20.696 | -22.569 | -21.924 | -10.460 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 12.823 | 13.659 | 14.101 | 17.676 | 25.642 |
| 存貨周轉天數 (天) | 297.789 | 305.027 | 301.598 | 290.659 | 271.703 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 26/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
